UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030616
Receipt number R000034732
Scientific Title Investigation of diurnal variation of serum uric acid level in daily living situation
Date of disclosure of the study information 2019/04/01
Last modified on 2017/12/28 16:01:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of diurnal variation of serum uric acid level in daily living situation

Acronym

Daily fluctuation of serum uric acid level

Scientific Title

Investigation of diurnal variation of serum uric acid level in daily living situation

Scientific Title:Acronym

Daily fluctuation of serum uric acid level

Region

Japan


Condition

Condition

Normal healthy subjects

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigation of diurnal variation of serum uric acid level

Basic objectives2

Others

Basic objectives -Others

Investigation of diurnal variation

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Investigation of diurnal variation of serum uric acid level

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Persons who have full ethical and regulatory approval and themselves and parental guardian give written informed consent
2.Healthy men and women who have serum uric acid value less than 8.0 mg / dL, and have never suffered a gout symptom
3.Healthy Japanese over 20 years old

Key exclusion criteria

1.Persons receiving medications such as uric acid levels, hypertension, diabetes, etc.
2.Pregnancy, breast-feeding, or pregnancy planning person
3.Those who are scheduled to undergo surgery / hospitalization, etc. for two months before and after the examination period (November 2017 to February 2018)

Target sample size

7


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shuichi Segawa

Organization

SAPPORO HOLDINGS Ltd.

Division name

Frontier Laboratory for Value Creation

Zip code


Address

10 Okatohme, Yaizu city, Shizuoka, 425-0013 JAPAN

TEL

054-629-7982

Email

Syuuichi.segawa@sapporoholdings.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shuichi Segawa

Organization

SAPPORO HOLDINGS Ltd.

Division name

Frontier Laboratory for Value Creation

Zip code


Address

10 Okatohme, Yaizu city, Shizuoka, 425-0013 JAPAN

TEL

054-629-7982

Homepage URL


Email

Syuuichi.segawa@sapporoholdings.co.jp


Sponsor or person

Institute

SAPPORO HOLDINGS Ltd.

Institute

Department

Personal name



Funding Source

Organization

SAPPORO HOLDINGS Ltd.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 12 Month 13 Day

Date of IRB


Anticipated trial start date

2017 Year 12 Month 18 Day

Last follow-up date

2018 Year 03 Month 31 Day

Date of closure to data entry

2018 Year 04 Month 30 Day

Date trial data considered complete

2018 Year 04 Month 30 Day

Date analysis concluded

2018 Year 06 Month 30 Day


Other

Other related information

Investigation of diurnal variation of serum uric acid level in daily living situation


Management information

Registered date

2017 Year 12 Month 28 Day

Last modified on

2017 Year 12 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034732


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name